Dr. Jennifer Serwanga, PhD
Dr. Jennifer Serwanga is a cellular Immunologist in the area of HIV/AIDS. She received her PhD training at Murdoch University, Western Australia, after accomplishing a BVM degree at Makerere University, Kampala. She is a scientific leader in Immunology, Basic Science programme where she takes charge of a team that aims to improve understanding of correlates of protection in HIV-1 disease progression, resistance to infection and HIV-1 super infection that will inform relevant vaccine formulation.
She is directly involved in the research activities undertaken by the team, in mentoring their career development, and in providing targeted training to support their undertaken research. The involved research areas include: studies to evaluate alternative reagents for assessing clade A and D cellular responses; screening clade A and D infected populations for correlates of broadly neutralising antibodies; evaluating pre-existing immunity to Adenoviruses to provide information relevant for vaccine design; and defining T-Cell correlates of protection in HIV clade A and D populations.
Dr. Serwanga is involved in developing Immunology capacity in the country by supporting laboratory capacity building, training in the annual ‘Immunology in the tropics’ course and providing methodological support and training in flow cytometry and neutralisation assay procedures. Over the years, she has taken lead in coordinating the Institutional effort to mitigate consequences associated with handling and working with potentially infectious hazardous chemical and biological agents. She currently serves on Ministry of Health advisory panels including the National Infection Control Committee and the National Committee for the Laboratory Containment of Polio.